Person: KILIÇOĞLU, ALİ GÜVEN
20 results
Search Results
Now showing 1 - 10 of 20
Publication Mentalization in female adolescents with non-suicidal self-injury and alexithymic and depressive features in their parents.(2021-05-04T00:00:00Z) Tekden, Mehmet; Kılıçoğlu, Ali Güven; Mutlu, Caner; Karaçetin, Gül; KILIÇOĞLU, ALİ GÜVENPublication 3240 mg long acting methylphenidate intake for suicide attempt(2014-03-01T00:00:00Z) Kilicoglu, Ali Güven; Ipek, Hamiyet; Mutlu, Caner; Dogan, Halil; Avci, Akkan; Erdogan, Ayten; KILIÇOĞLU, ALİ GÜVENPharmacotherapy is frequently used to treat symptoms of attention-deficit/hyperactivity disorder (ADHD), the most common neurobehavioral disorder of childhood. There are a few reported cases of overdose for suicide attempts or abuse with methylphenidate in current literature. Majority of these cases fully recovered after supportive therapy. We present a patient who ingested 3240 mg long acting methylphenidate for suicide attempt. He experienced increase in heart beat rate and blood pressure but he did not have additional symptoms. Although no serious neurological or cardiovascular event happened in this case, the supervised stimulant use is needed in child and adolescent population. Further studies are needed to evaluate the effect of methylphenidate overdose.Publication Impact of end-stage renal disease on psychological status and quality of life(2016-12-01T00:00:00Z) Kilicoglu, Ali Güven; Bahali, Kayhan; Canpolat, Nur; Bilgic, Ayhan; Mutlu, Caner; Yalcin, Ozhan; Pehlivan, Gulseren; Sever, Lale; KILIÇOĞLU, ALİ GÜVENBackground: The aim of this study was to assess depression, anxiety, and quality of life (QOL) in a cohort of children and adolescents with end-stage renal disease (ESRD), to compare these findings with healthy controls, and to evaluate the association between these psychological symptoms, QOL, and clinical variables related to ESRD.Publication Caregiver burden and related factors in caregivers of patients with childhood-onset systemic lupus erythematosus.(2021-08-03T00:00:00Z) Uzuner, Selcuk; Durcan, Gizem; Sahin, Sezgin; Bahali, Kayhan; Barut, Kenan; Kilicoglu, Ali Güven; Adrovic, Amra; Bilgic, Ayhan; Kasapcopur, Ozgur; UZUNER, SELÇUK; KILIÇOĞLU, ALİ GÜVENPublication Treatment compliance predictors in Type 1 Diabetes Mellitus child and adolescent patients(2019-05-05) kılıçoğlu, ali güven; Zadehgan Afshord, Telli; ÖZGEN, İLKER TOLGA; ÖRENGÜL, ABDURRAHMAN CAHİD; CESUR, YAŞAR; KILIÇOĞLU, ALİ GÜVEN; ÖZGEN, İLKER TOLGA; ÖRENGÜL, ABDURRAHMAN CAHİD; CESUR, YAŞARPublication Impact of enuresis nocturna on health-related quality of life in children and their mothers(2014-12-01T00:00:00Z) Kilicoglu, Ali Güven; Mutlu, C.; Bahali, M. K.; Adaletli, H.; Gunes, H.; Duman, H. Metin; Toz, H. Ipek; Uneri, O. S.; KILIÇOĞLU, ALİ GÜVENObjective: Nocturnal enuresis (NE) is a common childhood disorder. As children age and NE persists, it may become more stressful for both them and their caregivers. The aim of the present study was to assess the impact of NE on the quality of life of children who were diagnosed with NE, and their mothers, and to compare the results with a healthy control group.Publication The impact of Juvenile Systemic Lupus Erythematosus onpsycho-social status(2017-05-01T00:00:00Z) UZUNER, SELÇUK; ŞAHİN, SEZGİN; durcan, gizem; adrovic, amra; BARUT, KENAN; KILIÇOĞLU, Ali Güven; BİLGİÇ, AYHAN; bahalı, kayhan; KASAPÇOPUR, ÖZGÜR; UZUNER, SELÇUK; KILIÇOĞLU, ALİ GÜVENPublication Evaluation of Executive Functions in Children with Rheumatic Heart Diseases.(2021-10-21T00:00:00Z) Aliyeva, Nigar; Yozgat, Yilmaz; Bakhshaliyev, Nijad; Afshord, Telli Zadehgan; Yozgat, Can Yilmaz; Kilicoglu, Ali Güven; KILIÇOĞLU, ALİ GÜVENPublication Risperidone use in preschool children with aggressive and destructive behavioral symptoms(2015-06-01T00:00:00Z) Mutlu, Caner; Sukran Uneri, Ozden; Tanidir, Canan; Gunes, Hatice; Copur, Mazlum; Kilicoglu, Ali Güven; Adaletli, Hilal; Ipek, Hamiyet; Erdogan, Ayten; KILIÇOĞLU, ALİ GÜVENObjective: We aimed to investigate the prevalence and mode of risperidone use in preschool aged children admitted with a chief complaint of aggressive and destructive behavioral symptoms. Methods: In this retrospective chart review study, medical records of the patients were reviewed for age, gender, primary and comorbid diagnoses, dosage and duration of risperidone treatment. Dosage and duration of risperidone treatment were compared among primary diagnoses. Results: In 2790 children prevalence of risperidone use was 18.5% (n=516). Mean age was 4.86 +/- 1.12 years. Of these patients, %74.4 had primary diagnosis of a disruptive behavior disorder (DBD). Mean starting dosage of risperidone was 0.35 mg/day and mean maintenance dosage was 0.52 mg/day. The mean length of treatment was 4.9 months. Starting and maintenance doses were significantly higher and treatment duration was longer in patients with mental retardation (MR) than in those with DBDs. Conclusion: In preschoolers, risperidone is frequently used to control aggressive and destructive behavioral symptoms which may improve with higher doses and longer treatment in those with MR. The development of evidence-based treatment modalities for children with aggressive and destructive behaviors necessitates controlled studies and confirmation of their pertinence to clinical practice.Publication The relationship between psychological symptoms, lung function and quality of life in children and adolescents with non-cystic fibrosis bronchiectasis.(2014-09-01T00:00:00Z) BAHALI, K; GEDIK, AH; BILGIC, A; Cakir, ERKAN; Ustabas, Kahraman; Keskin, Osmanoglu; UZUNER, SELÇUK; KILICOGLU, ALİ GÜVEN; ÇAKIR, ERKAN; USTABAŞ KAHRAMAN, FEYZA; UZUNER, SELÇUK; KILIÇOĞLU, ALİ GÜVEN